Effect of Combination Therapy of Ezetimibe and Rosuvastatin on Regression of Coronary Atherosclerosis in Patients With Coronary Artery Disease-Reference-Cited by-同舟云学术

Effect of Combination Therapy of Ezetimibe and Rosuvastatin on Regression of Coronary Atherosclerosis in Patients With Coronary Artery Disease

Published:2015 Issue:3 Volume:56 Page:278-285
ISSN:1349-2365
Container-title:International Heart Journal
language:en
Short-container-title:Int. Heart J.

Author:

Masuda Jun¹,Tanigawa Takashi¹,Yamada Tomomi²,Nishimura Yuki³,Sasou Takashi⁴,Nakata Tomoyuki¹,Sawai Toshiki¹,Fujimoto Naoki¹,Dohi Kaoru¹,Miyahara Masatoshi⁵,Nishikawa Masakatsu³,Nakamura Mashio¹,Ito Masaaki¹

Affiliation:

1. Department of Cardiology and Nephrology, Mie University Graduate School of Medicine

2. Department of Clinical Epidemiology and Biostatistics, Graduate School of Medicine, Osaka University

3. Clinical Research Support Center, Mie University Hospital

4. Department of Clinical Engineering, Mie University Hospital

5. Division of Cardiology, Mie Heart Center

Publisher

International Heart Journal (Japanese Heart Journal)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference29 articles.

1. 1. Lewington S, Whitlock G, Clarke R, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007; 370: 1829-39. (Review)

2. 2. Baigent C, Blackwell L, Emberson J, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010; 376: 1670-81.

3. 3. Mills EJ, Rachlis B, Wu P, Devereaux PJ, Arora P, Perri D. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients. J Am Coll Cardiol 2008; 52: 1769-81.

4. 4. Nissen SE, Tuzcu EM, Schoenhagen P, et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004; 291: 1071-80.

5. 5. Nissen SE, Nicholls SJ, Sipahi I, et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 2006; 295: 1556-65.

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clinical relevance of the reversal of coronary atherosclerotic plaque;European Journal of Internal Medicine;2024-08

2. Atherosclerotic coronary plaque regression from lipid-lowering therapies: A meta-analysis and meta-regression;American Journal of Preventive Cardiology;2024-06

3. Management of Coronary Vulnerable Plaque With Medical Therapy or Local Preventive Percutaneous Coronary Intervention;JACC: Asia;2024-06

4. Effect of ezetimibe–statin combination therapy vs. statin monotherapy on coronary atheroma phenotype and lumen stenosis in patients with coronary artery disease: a meta-analysis and trial sequential analysis;Frontiers in Pharmacology;2024-05-13

5. Targeting systemic inflammation in metabolic disorders. A therapeutic candidate for the prevention of cardiovascular diseases?;Pharmacological Research;2024-02